Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02675439 |
Title | Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Aduro Biotech, Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Colorado School of Medicine | Aurora | Colorado | 80045 | United States | Details | |
University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21287 | United States | Details | |
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Columbia University Medical Center-Herbert Irving Pavilion | New York | New York | 10032 | United States | Details | |
University of Texas/MD Anderson Cancer Center MD Anderson PSC | Houston | Texas | 77030-4009 | United States | Details | |
University of Utah Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | United States | Details |